Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

Innovent and NeoCura to Test PD-1/mRNA Vaccine Combination for Cancer

CANbridge Doses First Patient in Phase II GBM Trial

Angel Pharma to Start China Trial of ITK Inhibitor for Lymphoma

Kintor Approved to Start Phase I Trial of Dual-Targeting Antibody

Zai Lab Says Novel Antibacterial Effective Against a Drug Resistant Pathogen

ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China